Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma

Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma ( Dr Sana Al-Sukhun - Al Hyatt Oncology Practice, Amman, Jordan )
21 Apr 2023

The importance of providing post-treatment care to cancer survivors

Dr Lidia Schapira - Stanford Medicine, California, USA
The importance of providing post-treatment care to cancer survivors ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023

Cancer Survivorship

Dr Lidia Schapira - Stanford Medicine, California, USA
Cancer Survivorship ( Dr Lidia Schapira - Stanford Medicine, California, USA )
20 Apr 2023

Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM

Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA
Encouraging safety and efficacy for REGN5459, a BCMA×CD3 bispecific antibody with low CD3 affinity, in patients with RRMM ( Dr Attaya Suvannasankha - Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, USA )
20 Apr 2023

Cancer Care in Older Adults and Special Population

Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA
Cancer Care in Older Adults and Special Population ( Dr Don Dizon - Rhode Island Hospital, Rhode Island, USA )
20 Apr 2023

The clinical impact of the Choosing Wisely project

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
The clinical impact of the Choosing Wisely project ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC

Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA
ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC ( Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA )
20 Apr 2023

Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival

Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA
Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival ( Prof Daniel Saltzman - University of Minnesota, Minneapolis, USA )
20 Apr 2023

Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC

Prof Pierce Chow - Duke-NUS Medical School, Singapore
Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC ( Prof Pierce Chow - Duke-NUS Medical School, Singapore )
20 Apr 2023

A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients

Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA
A single fractionated cycle of 225Ac-J591 shows preliminary efficacy on mCRPC patients ( Dr Jones Nauseef - Weill Cornell Medicine, New York City, USA )
20 Apr 2023

IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours

Dr Matthew Taylor - Providence Cancer Institute, Portland, USA
IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours ( Dr Matthew Taylor - Providence Cancer Institute, Portland, USA )
20 Apr 2023